2018 - Pharmacist Digest

STAT+: Wyden claims Pfizer used a ‘colossal’ scheme to avoid paying billions in U.S. taxes

STAT

MARCH 27, 2025

for 2018 and 2020. In what one U.S. lawmaker described as possibly the “largest tax-dodging scheme” by a pharmaceutical company in history, Pfizer sold $20 billion in medicines to U.S. customers, but treating the profits as foreign income for tax purposes.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Opinion: HIV self-testing is easy, effective — and underutilized

STAT

MARCH 13, 2025

In May 2024, the Massachusetts Department of Public Health released a troubling report on a cluster of HIV infections, with more than 200 new cases since 2018 attributable to injection drug use in the Boston region.

STAT+: Pharma’s reputation with patient groups dips again, mostly due to pricing issues

STAT

APRIL 28, 2025

In 2021, for instance, 59% of companies scored highly, compared with 41% in 2018. The back-to-back declines come after 60% of patient groups believed the industry fared well thanks to the initial response of many companies to quickly develop salves for the Covid-19 pandemic. Continue to STAT+ to read the full story…

Drug Pricing

Drug Pricing Drug Development

Incubators and innovation hubs: Accelerating entrepreneurship in life sciences

Express Pharma

NOVEMBER 30, 2024

References [link] [link] per cent20S per cent26amp per cent3BT_Incubator_ %2016–5-2018.pdf pdf [link] [link] [link] [link] [link] [link] The post Incubators and innovation hubs: Accelerating entrepreneurship in life sciences appeared first on Express Pharma.

Communication

India’s Growing Importance in Generic Drug API Manufacturing

Drug Patent Watch

DECEMBER 10, 2024

Hyderabad’s Pharma City, which has been under construction since 2018, is a significant example of this initiative. These parks are critical in reducing India’s reliance on China and making the country an attractive location for pharmaceutical manufacturing.

Pharmaceutical Manufacturing

Making Medicines Affordable: The Role of Generics

Drug Patent Watch

DECEMBER 26, 2024

Making Prescription Drugs Affordable. Retrieved from [link] National Academies of Sciences, Engineering, and Medicine. Making Medicines Affordable: A National Imperative. Retrieved from [link] National Academies of Sciences, Engineering, and Medicine. Retrieved from [link] Source

Drug Pricing

Drug Pricing Biosimilars

Operating losses of e-pharmacies seen falling below 10 per cent next fiscal

Express Pharma

DECEMBER 24, 2024

References Operating losses at the Ebitda level, where Ebitda is earnings before interest, taxes, depreciation and amortisation Wellness products refer to various health, dietary and fitness supplements The Ministry of Health and Family Welfare published draft Rules on 28th August 2018 to amend the Drugs and Cosmetics Rules, 1945, aiming to regulate (..)

Online Pharmacies

How to Achieve CDMO Operational Excellence

Drug Patent Watch

DECEMBER 11, 2024

2018, March 29). Lean & Operational Excellence in Life Science CDMO’s. Retrieved from [link] GBI Bio. 2024, February 29). Overcoming Scalability in Biologics: CDMO Strategies for Success. Retrieved from [link] Pharmasalmanac. Transforming A CDMO Using an Operational Excellence Approach. Retrieved from [link] Source

Clearsynth receives government backing to advance India’s deuterated chemical production

Express Pharma

JULY 9, 2025

Collaboration with HWB In the year 2018, the Heavy Water Board recognised the potential of non-nuclear applications and took the first step in collaborating with two Indian Private organisations to encourage the development and manufacturing of deuterated products.

Compounding

Compounding Pharmaceutical Manufacturing Labelling

Advancing endotoxin testing with sustainable recombinant LAL solutions

European Pharmaceutical Review

JULY 10, 2025

The regulatory confidence becomes evident when considering that pharmaceutical products tested using rFC have received approval since 2018, demonstrating practical acceptance of recombinant methods. USP Chapter 86, now official, describes alternative methods alongside traditional LAL testing in Chapter 85, treating both rFC and rCR equally.

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies

The EU AI Act: will regulation drive life science innovation away from Europe?

European Pharmaceutical Review

NOVEMBER 28, 2024

When the General Data Protection Regulation (GDPR) 1 came into effect in 2018, this appeared to accelerate the migration out of Europe for pharmaceutical clinical trials. This was not so much due to non-compliance but stemmed from regulatory ambiguity.

Documentation

Documentation Compounding

Pharmacogenomics

RX Note

DECEMBER 25, 2024

2009 Clopidogrel Therapy and CYP2C19 Genotype, 2018 EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine, 2020 Tramadol Therapy and CYP2D6 Genotype, 2021

Labelling

Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes

Express Pharma

MARCH 20, 2025

Milken Institute; 2018. 2022;327(6):534-545. doi:10.1001/jama.2022.0078 2022.0078 Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17) – The Lancet Diabetes & Endocrinology Waters H, Graf M. Americas Obesity Crisis: The Health and Economic Costs of Excess Weight.

Diabetes

Diabetes Labelling Communication

Labelling of Dispensed Medicine

RX Note

DECEMBER 25, 2024

External Links Guide to Good Dispensing Practice, 2016 Expanding the Universal Medication Schedule: a patient-centred approach, 2014 A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence, 2016 Safer dispensing labels for prescription medicines, 2018 National Standard for Labelling Dispensed Medicines, 2021 MOH (..)

Labelling

Labelling Dosage Packaging Communication

DCGI launches Professional Development Programme in digital health for pharmacists

Express Pharma

FEBRUARY 11, 2025

The Academy of Digital Health Sciences, founded in 2018, provides digital health courses for doctors, nurses, pharmacists, and healthcare professionals. The post DCGI launches Professional Development Programme in digital health for pharmacists appeared first on Express Pharma.

Lupin and Avas launch NaMuscla in Italy

Express Pharma

JANUARY 28, 2025

NaMuscla, which has been designated orphan drug status, received EU marketing authorisation in December 2018. NaMusclareduces myotonia symptoms in people with NDM, resulting in a significant improvement in quality of life and other functional and clinical outcomes for patients.

Rusan Pharma Chairman Dr Navin Saxena receives Russia’s ‘Order of Friendship’ and ‘Memorial Medal’

Express Pharma

FEBRUARY 14, 2025

Dr Saxena joins an eminent group of Indians who have received the Order of Friendship , including chess grandmaster Viswanathan Anand (2018), former Member of Parliament Murli Manohar Joshi, scientist Dr A.S. This recognition fuels our commitment to innovation and cross-cultural solidarity.

Accretion Pharmaceuticals’ IPO to open on May 14 2025; Price band fixed at ₹96-101

Express Pharma

MAY 11, 2025

It has received several certifications, including ISO 9001:2015, ISO 14001:2015, and ISO 22000:2018. The promoters, Harshad Nanubhai Rathod, Vivek Ashok Kumar Patel, Mayur Popatlal Sojitra, and Hardik Mukundbhai Prajapati, established Accretion Pharmaceuticals in 2012. The company has registered 35.66 crore in the fiscal year 2024.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Diabetes

New guidance to aid cost-effectiveness analysis of new drugs

European Pharmaceutical Review

JANUARY 17, 2025

The [surrogate endpoints report] was developed following the challenges arising from changes in pharmaceutical clinical trials and regulation” They highlighted that products given conditional or accelerated approval by the European Medicines Agency (EMA) between 2011 and 2018 have predominantly relied on non-validated surrogate endpoints this (..)

Drug Development

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Pharmacy Times

JUNE 20, 2025

December 13, 2018. American Oncology Network. August 8, 2024. Accessed May 15, 2025. How your oncology peers manage the complexities of care. Oncology Live ®. Accessed May 15, 2025. Desimone R. Improve work performance with a focus on employee development. December 12, 2019. Updated January 19, 2024. Accessed May 15, 2025.

Pharmacy Technician

Pharmacy Technician Compounding Compounding Pharmacies Biosimilars

Mankind Pharma and Innovent Biologics partner to license and commercialise Sintilimab

Express Pharma

DECEMBER 26, 2024

TYVYT(sintilimab injection), is one of the top therapy choices in immunotherapy, and has already benefited millions of cancer patients since its launch in 2018. Under the agreement, Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India.

Self-Care Measures for Preventing and Managing Dysmenorrhea

Pharmacy Times

JUNE 20, 2025

December 2018. link] articles/2018/12/dysmenorrhea-and-endometriosis-in-the-adolescent 4. American Pharmaceutical Association; 2025. Dysmenorrhea and endometriosis in the adolescent. American College of Obstetricians and Gynecologists. Accessed April 28, 2025. Smith RP, Kaunitz AM. UpToDate.

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management

NHC Submits Comments on CMS’ Proposed Rule on Marketplace Integrity and Affordability

Putting Patients First Blog

APRIL 14, 2025

12 (December 2022), [link] 3 National Academies of Sciences, Engineering, and Medicine, Health-Care Utilization as a Proxy in Disability Determination (Washington, DC: National Academies Press, March 1, 2018), chap. Finkelstein et al., 2, Factors That Affect Health-Care Utilization, https ://www.ncbi.nlm.nih.gov/books/NBK500097/.

Insurance Coverage and Processing

Insurance Coverage and Processing Documentation Hospitals Communication

Infliximab Biosimilar Initiation Has Increased in Pediatric IBD, Study Finds

Pharmacy Times

JULY 8, 2025

1,2 The authors wrote that a 2018 survey from the Crohn’s and Colitis Foundation reported that health care professionals expressed discomfort when prescribing biosimilars in the pediatric population compared with adults. One patient started Inflectra in 2016 and 2017. There was a slow uptake of infliximab biosimilar use among the ICN centers.

The GLP-1 Gold Rush: Why Compounded Alternatives Are a Risky Bet

Pharmaceutical Commerce

JULY 16, 2025

This has driven a staggering surge in prescriptions, with some reports indicating growth of over 5,000% since 2018 in the United States. Justin Kozak The buzz around GLP-1 agonists like Ozempic and Wegovy is undeniable, fueled by social media virality and impressive clinical results.

Compounding

Compounding Insurance Coverage and Processing Drug Pricing Compounding Pharmacies

Episode 1007: What the New SCCM Sedation Guidelines Say About Melatonin

Pharmacy Joe

MARCH 9, 2025

Episode 1007: What the New SCCM Sedation Guidelines Say About Melatonin Subscribe on iTunes , Android , or Stitcher The 2018 SCCM guidelines on pain, agitation, delirium, immobility, and sleep have received a focused update which has been published in the journal Critical Care Medicine.

Inpatient

Inpatient Hospitals

The rise of Fixed-Dose Combinations (FDCs): What it means for pharma players

Express Pharma

APRIL 7, 2025

In September 2018, the Indian government banned 328 FDCs after an expert committee found that many lacked therapeutic justification and posed potential health risks. Regulatory actions and concerns Despite their growing adoption, FDCs have been subject to increased regulatory scrutiny due to concerns over irrational combinations.

Generic Medicine

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Diabetes

ADA: Vertex closer to weaning type 1 diabetics off insulin

pharmaphorum

JUNE 24, 2025

Skip to main content Tuesday 24 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars

Grail plans FDA filing for cancer blood test after new trial

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars

Earwax (Cerumen) Impaction

RX Note

MARCH 31, 2025

External Links Ear drops for the removal of earwax, 2018 FDA Takes a Stand Against Ear Candling, 2010 Summary If any ear wax remains despite treatment to soften the wax for 3-5 days, referral for ear irrigation may be advisable.

Community Pharmacies

Pharmaceutical training boost: how the growth and skills levy could shape industry development

European Pharmaceutical Review

FEBRUARY 17, 2025

While this investment led to a seven percent rise in annual apprenticeship starts within the life sciences sector between 2018/19 and 2022/23, industry leaders have consistently argued that the narrow focus on apprenticeships left gaps in training provision. billion in 2017/18 to 2.5 billion in 2023/24.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

The unsustainability of clinical trials and need for transformative change

Pharmaceutical Technology

JULY 11, 2025

The rising volume of clinical trials increases demand and competition for patients The number of oncology assets in the clinical development pipeline has increased by 13% annually over five years (2018-2022) 1. On paper, this sounds like a positive time for medical innovation.

Drug Pricing

Drug Pricing Hospitals Medical Records Drug Development

MRI and Astellas to support Japanese drug-discovery startups

Pharmaceutical Business Review

JUNE 16, 2025

Since 2018, the MRI has been tasked with managing MEDISO and has been supporting startups in the drug discovery sector to bring their intellectual property to the market.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Is DTC pharma advertising coming to an end?

PharmaVoice

JUNE 18, 2025

Biggest spenders DTC ads are almost exclusively leveraged for brand name drugs, with two-thirds of that spending concentrated on just 39 drugs between 2016 and 2018, according to a Government Accountability Office report. Some of the biggest spenders are shelling out millions to get their brands in front of American audiences.

Compounding

Compounding Diabetes Packaging

Cell and gene therapy market set to grow at 44% CAGR through 2030: GlobalData

Express Pharma

MARCH 25, 2025

This approval was followed by Takeda Pharmaceuticals Alofisel (darvadstrocel), which received approval from the European Medicines Agency in 2018 and from Japans Pharmaceuticals and Medical Devices Agency in 2021.

Compounding

Leading the Charge in Equine Veterinary Care: An Innovative Treatment for Equine Gastric Disease

epicur

MAY 1, 2025

Available from: [link] (2018), Efficacy of long-acting injectable omeprazole (LAIOMEP) in the management of equine glandular gastric disease (EGGD) and equine squamous gastric disease (ESGD). . & Gough, S.L. Pharmaceutical treatment of equine glandular gastric disease: A contextualised review of recent developments.

Study Reveals Alarming Gaps in HER2 Therapy Access for Patients With Breast Cancer

Pharmacy Times

JULY 1, 2025

031), and diagnosis between 2016 and 2018 (OR 1.93, P < 001) as well as 2019 and 2020 (1.88, P < 001). in 2016, representing a period of rapid uptake—and usage was consistently high from 2016 to 2018. 3 The utilization of HER2 therapies increased from 64.6% in 2013 to 80.9%

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

PharmaTech

JUNE 24, 2025

In 2018, following decades of research and development, the first RNA-based therapy, Onpattro (patisiran), from Alnylam Pharmaceuticals reached the market (10). /Moderna with LNP-delivered mRNA-4157/V940 in combination with Keytruda (pembrolizumab) also for melanoma (8–9). News Release. 3 June 2024. News Release. Intellia Therapeutics.

Vaccines

Vaccines Dosage Drug Development Immunization

Makary: Drugs don’t have to take 10 years to get to market

pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Pricing

NHC Responds to Joint CMS–ASTP/ONC RFI on Improving Health Technology

Putting Patients First Blog

JUNE 16, 2025

9 (2018): 1259–1265, [link] [14] LeadingAge and the Strategic Health Information Exchange Collaborative (SHIEC), Health Information Exchange (HIE): A Primer and Provider Selection Guide , accessed June 9, 2025, [link] [15] LeadingAge and SHIEC, HIE: A Primer and Provider Selection Guide. [16] 9 (2018): 1259–1265. 9 (2018): 1259–1265.

Documentation

Documentation Communication Immunization Immunity

Incyte replaces CEO Hoppenot with dealmaker Meury

BioPharma Dive

JUNE 26, 2025

However, it flamed out in testing in 2018 and Incyte was forced to pivot research toward other candidates. Early in Hoppenot’s tenure, the answer looked like a cancer medicine called epacadostat, which Incyte believed could become a cornerstone of immunotherapy combinations. Since then, Incyte has had some success building out its portfolio.

Drug Pricing

Drug Pricing Drug Development Vaccines

What to Expect When you are Expecting…a Government Shutdown

FDA Law Blog: Biosimilars

FEBRUARY 18, 2025

The answers below are based on my experience as a reviewer and compliance officer at FDA during the 5-week 2018/2019 government shutdown. During the 5-week shutdown in 2018/2019, PDUFA funding was the most robust and could have funded several months of review operations. What does it mean for FDA staff?

GRIN Therapeutics: Seeking to address unmet needs in rare neurodevelopmental disorders

pharmaphorum

JUNE 30, 2025

Skip to main content Monday 30 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Development

STAT+: Wyden claims Pfizer used a ‘colossal’ scheme to avoid paying billions in U.S. taxes

Opinion: HIV self-testing is easy, effective — and underutilized

Trending Sources

STAT+: Pharma’s reputation with patient groups dips again, mostly due to pricing issues

Incubators and innovation hubs: Accelerating entrepreneurship in life sciences

India’s Growing Importance in Generic Drug API Manufacturing

Making Medicines Affordable: The Role of Generics

Operating losses of e-pharmacies seen falling below 10 per cent next fiscal

How to Achieve CDMO Operational Excellence

Clearsynth receives government backing to advance India’s deuterated chemical production

Advancing endotoxin testing with sustainable recombinant LAL solutions

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

The EU AI Act: will regulation drive life science innovation away from Europe?

Pharmacogenomics

Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes

Labelling of Dispensed Medicine

DCGI launches Professional Development Programme in digital health for pharmacists

Lupin and Avas launch NaMuscla in Italy

Rusan Pharma Chairman Dr Navin Saxena receives Russia’s ‘Order of Friendship’ and ‘Memorial Medal’

Accretion Pharmaceuticals’ IPO to open on May 14 2025; Price band fixed at ₹96-101

New guidance to aid cost-effectiveness analysis of new drugs

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Mankind Pharma and Innovent Biologics partner to license and commercialise Sintilimab

Self-Care Measures for Preventing and Managing Dysmenorrhea

NHC Submits Comments on CMS’ Proposed Rule on Marketplace Integrity and Affordability

Infliximab Biosimilar Initiation Has Increased in Pediatric IBD, Study Finds

The GLP-1 Gold Rush: Why Compounded Alternatives Are a Risky Bet

Episode 1007: What the New SCCM Sedation Guidelines Say About Melatonin

The rise of Fixed-Dose Combinations (FDCs): What it means for pharma players

ADA: Vertex closer to weaning type 1 diabetics off insulin

Grail plans FDA filing for cancer blood test after new trial

Earwax (Cerumen) Impaction

Pharmaceutical training boost: how the growth and skills levy could shape industry development

The unsustainability of clinical trials and need for transformative change

MRI and Astellas to support Japanese drug-discovery startups

Is DTC pharma advertising coming to an end?

Cell and gene therapy market set to grow at 44% CAGR through 2030: GlobalData

Leading the Charge in Equine Veterinary Care: An Innovative Treatment for Equine Gastric Disease

Study Reveals Alarming Gaps in HER2 Therapy Access for Patients With Breast Cancer

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

Makary: Drugs don’t have to take 10 years to get to market

NHC Responds to Joint CMS–ASTP/ONC RFI on Improving Health Technology

Incyte replaces CEO Hoppenot with dealmaker Meury

What to Expect When you are Expecting…a Government Shutdown

GRIN Therapeutics: Seeking to address unmet needs in rare neurodevelopmental disorders

Stay Connected